Logo image of ALAVI.PA

ADVINI (ALAVI.PA) Stock Fundamental Analysis

EPA:ALAVI - Euronext Paris - Matif - FR0000053043 - Common Stock - Currency: EUR

13  -0.2 (-1.52%)

Fundamental Rating

2

ALAVI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 24 industry peers in the Beverages industry. ALAVI has a bad profitability rating. Also its financial health evaluation is rather negative. ALAVI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALAVI had negative earnings in the past year.
In the past year ALAVI had a positive cash flow from operations.
In multiple years ALAVI reported negative net income over the last 5 years.
In the past 5 years ALAVI always reported a positive cash flow from operatings.
ALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFALAVI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M 40M

1.2 Ratios

The Return On Assets of ALAVI (-3.19%) is worse than 91.67% of its industry peers.
Looking at the Return On Equity, with a value of -17.22%, ALAVI is doing worse than 91.67% of the companies in the same industry.
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROIC N/A
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ALAVI.PA Yearly ROA, ROE, ROICALAVI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10

1.3 Margins

With a Gross Margin value of 35.70%, ALAVI is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ALAVI has grown nicely.
ALAVI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
ALAVI.PA Yearly Profit, Operating, Gross MarginsALAVI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30

More info and screens

1

2. Health

2.1 Basic Checks

ALAVI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALAVI has less shares outstanding
The number of shares outstanding for ALAVI has been reduced compared to 5 years ago.
Compared to 1 year ago, ALAVI has a worse debt to assets ratio.
ALAVI.PA Yearly Shares OutstandingALAVI.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALAVI.PA Yearly Total Debt VS Total AssetsALAVI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

ALAVI has an Altman-Z score of 0.82. This is a bad value and indicates that ALAVI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.82, ALAVI is doing worse than 87.50% of the companies in the same industry.
The Debt to FCF ratio of ALAVI is 38.51, which is on the high side as it means it would take ALAVI, 38.51 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALAVI (38.51) is worse than 70.83% of its industry peers.
A Debt/Equity ratio of 2.65 is on the high side and indicates that ALAVI has dependencies on debt financing.
ALAVI's Debt to Equity ratio of 2.65 is on the low side compared to the rest of the industry. ALAVI is outperformed by 91.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Altman-Z 0.82
ROIC/WACCN/A
WACC4.75%
ALAVI.PA Yearly LT Debt VS Equity VS FCFALAVI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.91 indicates that ALAVI may have some problems paying its short term obligations.
The Current ratio of ALAVI (0.91) is worse than 66.67% of its industry peers.
A Quick Ratio of 0.30 indicates that ALAVI may have some problems paying its short term obligations.
With a Quick ratio value of 0.30, ALAVI is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.3
ALAVI.PA Yearly Current Assets VS Current LiabilitesALAVI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ALAVI have decreased strongly by -423.08% in the last year.
ALAVI shows a decrease in Revenue. In the last year, the revenue decreased by -4.22%.
Measured over the past years, ALAVI shows a small growth in Revenue. The Revenue has been growing by 2.21% on average per year.
EPS 1Y (TTM)-423.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%

3.2 Future

Based on estimates for the next years, ALAVI will show a very strong growth in Earnings Per Share. The EPS will grow by 50.76% on average per year.
ALAVI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.70% yearly.
EPS Next Y-24.26%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
EPS Next 5YN/A
Revenue Next Year-3.21%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.7%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALAVI.PA Yearly Revenue VS EstimatesALAVI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
ALAVI.PA Yearly EPS VS EstimatesALAVI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALAVI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 70.12, which means the current valuation is very expensive for ALAVI.
87.50% of the companies in the same industry are cheaper than ALAVI, based on the Price/Forward Earnings ratio.
ALAVI is valuated expensively when we compare the Price/Forward Earnings ratio to 21.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 70.12
ALAVI.PA Price Earnings VS Forward Price EarningsALAVI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

ALAVI's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, ALAVI is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.32
EV/EBITDA 11.18
ALAVI.PA Per share dataALAVI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

ALAVI's earnings are expected to grow with 50.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.49%
EPS Next 3Y50.76%

More info and screens

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.08%, ALAVI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.78, ALAVI is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.47, ALAVI has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.08%

5.2 History

The dividend of ALAVI is nicely growing with an annual growth rate of 13.49%!
Dividend Growth(5Y)13.49%
Div Incr Years0
Div Non Decr Years0
ALAVI.PA Yearly Dividends per shareALAVI.PA Yearly Dividends per shareYearly Dividends per share 2023 0.1 0.2 0.3

5.3 Sustainability

ALAVI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of ALAVI is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-10.64%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
ALAVI.PA Yearly Income VS Free CF VS DividendALAVI.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M 30M

More info and screens

ADVINI

EPA:ALAVI (4/25/2025, 7:00:00 PM)

13

-0.2 (-1.52%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)07-24 2025-07-24
Inst Owners0.3%
Inst Owner ChangeN/A
Ins Owners23.83%
Ins Owner ChangeN/A
Market Cap51.22M
Analysts82
Price Target17.75 (36.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.08%
Yearly Dividend0.35
Dividend Growth(5Y)13.49%
DP-10.64%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-45.69%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 70.12
P/S 0.18
P/FCF 9.32
P/OCF 4.15
P/B 0.71
P/tB 1.63
EV/EBITDA 11.18
EPS(TTM)-3.3
EYN/A
EPS(NY)0.19
Fwd EY1.43%
FCF(TTM)1.39
FCFY10.73%
OCF(TTM)3.13
OCFY24.09%
SpS72.1
BVpS18.41
TBVpS7.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.19%
ROE -17.22%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.7%
FCFM 1.93%
ROA(3y)-0.64%
ROA(5y)-0.43%
ROE(3y)-3.94%
ROE(5y)-2.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.37%
GM growth 5Y9.57%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 38.51
Debt/EBITDA 14.48
Cap/Depr 43%
Cap/Sales 2.41%
Interest Coverage N/A
Cash Conversion 92.95%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.3
Altman-Z 0.82
F-Score6
WACC4.75%
ROIC/WACCN/A
Cap/Depr(3y)73.75%
Cap/Depr(5y)75%
Cap/Sales(3y)3.53%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-423.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%38.03%
EPS Next Y-24.26%
EPS Next 2Y50.49%
EPS Next 3Y50.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.22%
Revenue growth 3Y4.98%
Revenue growth 5Y2.21%
Sales Q2Q%-1.95%
Revenue Next Year-3.21%
Revenue Next 2Y-0.7%
Revenue Next 3Y0.7%
Revenue Next 5YN/A
EBIT growth 1Y-164.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year281.13%
EBIT Next 3Y74.8%
EBIT Next 5YN/A
FCF growth 1Y-44.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-38.82%
OCF growth 3Y-67.32%
OCF growth 5Y-52.31%